Eli Lilly teams with Pieris on HER2+ tumors; Opdivo + Yervoy best chemo in mesothelioma
Despite the FDA putting a partial clinical hold on its lead program only a few weeks ago, Boston-based Pieris Pharmaceuticals is plowing forward with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
